Delivery Order SPE2DR25D1103-SPE2DR26FE085
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,597.08 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Miebo 100% eye drops in 3ml units. The award is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of April 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $30,256.76 for MIEBO 100% eye drop supply (3ml units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The...
- The Defense Logistics Agency awarded a $5,859.32 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Miebo 100% eye drop in 3ML units. This firm fixed price delivery order, with an ultimate completion date of December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is non-competitive and will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a $3,202.62 delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Miebo 100% eye drop medication in 3ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the company's existing contract...
- The Defense Logistics Agency awarded a $5,607.96 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for supply of Miebo 100% eye drop in 3ml quantities. This is a firm fixed-price contract with an ultimate completion date of December 12, 2025, and represents a child delivery order under AmerisourceBergen's broader contract vehicle with DLA. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be conducted at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,458.02 by the Medical Supply Chain, a defense-focused federal agency, on September 29, 2025, for the supply of Miebo 100% eye drop medication in 3ML units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,778.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3 mL units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,217.58 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on December 10, 2025, with completion targeted for December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for $1,254.03 to supply MIEBO 100% Eye Drop in 3mL quantities. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of June 3, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical,...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE085Delivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,748.98 on November 25, 2025, for the supply of Miebo 100% eye drops (3ml). The Defense Logistics Agency (DLA) issued this competitively awarded, firm fixed-price delivery order, which is scheduled for completion by November 26, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation, reflecting the contractor's demonstrated capability to compete successfully in open federal procurement. As a critical pharmaceutical vendor for the Defense Health Agency and military healthcare systems, AmerisourceBergen supplies a comprehensive range of medical products to support federal medical procurement needs. This specific delivery order for specialty ophthalmic medication exemplifies the company's role in providing essential pharmaceutical commodities across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables flexible fulfillment of pharmaceutical and medical supply requirements for military and veteran healthcare programs on a global basis, with AmerisourceBergen positioned as one of several anticipated vendors under the forthcoming Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 11/24/25 |